New Type 2 Diabetes Drugs at FDA Stage
Posted on: Wednesday, 14 June 2006, 18:00 CDT
Merck & Co. and Novartis AG are seeking U.S. government approval of new Type 2 diabetes drugs they claim have milder side effects than current treatments.
As Type 2 diabetes cases increase, the two drugmakers say Food and Drug Administration approval will help sufferers cut blood sugar without increasing their weight or retaining fluid.
Type 2 diabetes occurs in overweight people and has recently begun appearing more in children. It is preventable and treatable.
The Wall Street Journal reports the companies will also cash in on the DPP-IV inhibitors as analysts estimate an annual sale of $1 billion by 2010.
Source: United Press International
Related Articles
- Blue Cross and Blue Shield of Illinois Teams with Chicago Bears Coach Lovie Smith in Diabetes Awareness Drive
- Garlic Tablet Could Treat Diabetes I And II
- Understand the Key Factors That Will Contribute To the Success of the Next Generation of Anti-Diabetes Drugs
- Diabetes Seems to Be Rising
- Low-dose insulin doesn't affect kids' growth
- Clinical Trials Update: Aug. 12, 2005
- Body Talk; HEALTH NOTES: This Week: Diabetes Type I Cure Found
- DOCS CLOSING IN ON VACCINE FOR DIABETES ; Type 1 Jab to Be Tested on People
- Insmed Announces Expansion of Patent Portfolio in the Treatment of Diabetes; New European Patent Granted for SomatoKine
- Clinical Trials Update:&Nbsp;Oct. 18, 2004
Rating: 3.2 / 5 (6 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds